Skip to content

Tina-quant IgG Gen.2 08057915190Recalls & reported problems

Roche Diagnostics GmbH · Class 2

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
2
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 07613336121320), received between Sep 14, 2026 and Sep 17, 2026 — classified as 2 malfunctions.

The most frequently reported specific device problem is “High Test Results” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 2 reportsOct 2026: 0 reports2024202520262
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • High Test Results1
  • Low Test Results1

Patient problems

  • No Clinical Signs, Symptoms or Conditions2

Recent adverse event reports

The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.

  • MalfunctionSep 17, 2026Low Test Results

    Roche Diagnostics received a customer complaint regarding alleged discrepant Tina-quant IgG Gen.2 assay results for one cerebrospinal fluid (CSF) patient sample tested on the cobas 8000 cobas c 502 module.The initial result was 7.98 mg/L.The first repeat result was 404 mg/L with an invalidating data flag.The second repeat result at 1:10 manual dilution in decreased mode was 732 mg/L with a data flag; the final calculated result was 7320 mg/L.The third repeat result at 1:10 manual dilution was 7130 mg/L.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50800777 ↗
  • MalfunctionSep 14, 2026High Test Results

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50754528 ↗

Other IGG, ANTIGEN, ANTISERUM, CONTROL devices

All IGG, ANTIGEN, ANTISERUM, CONTROL devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page